Grantham, Mayo, Van Otterloo & Co (GMO)
RTO icon

Grantham, Mayo, Van Otterloo & Co (GMO)’s Rentokil RTO Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio RTO Stock Details RTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-21,600
Closed -$680K – 713
2026
Q1 		$680K Hold
21,600
– – ﹤0.01% 539
2025
Q4 		$636K Sell
21,600
-24,700
-53% -$686K ﹤0.01% 559
2025
Q3 		$1.17M Hold
46,300
– – ﹤0.01% 459
2025
Q2 		$1.11M Buy
+46,300
New +$1.07M ﹤0.01% 466

Other funds holding RTO

JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
GCM
Gates Capital Management New York $4.16B AUM 21% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.79B AUM 33.56% 1-Year Est. Return
Aristotle Capital Management
Aristotle Capital Management Los Angeles, California $47.7B AUM 13.92% 1-Year Est. Return
SL
Summitry LLC Foster City, California $3.04B AUM 17.05% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s RTO Position: Q2 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Rentokil (RTO) in Q2 2026, closing a stake of 21,600 shares — an estimated $680K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in RTO in Q2 2025 and held it in 4 quarters. The position peaked at $1.17M in Q3 2025. 285 funds tracked by Wall St. Rank hold RTO as of Q2 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Rentokil position as of Q2 2026 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 21,600 Rentokil shares in Q2 2026, an estimated $680K.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Rentokil in Q2 2025 and held it in 4 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Rentokil position peaked at $1.17M in Q3 2025.
  • 285 funds tracked by Wall St. Rank held Rentokil as of Q2 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2026, filed 13 Aug 2026.